Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-02-09 Purchase | 2023-02-27 10:52 am | Lexaria Bioscience Corp. | LEXX | TURKEL CATHERINE C. Director | 1,500 | $2.8446 | $4,267 | 9,900 (Direct) | View |
2019-05-20 Sale | 2019-05-22 4:12 pm | Novus Therapeutics Inc. | NVUS | TURKEL CATHERINE C. President | 9,537 | $1.9515 | $18,612 | 88,662 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-07-25 Option Award | 2023-07-25 1:44 pm | 2023-07-25 2028-07-25 | Lexaria Bioscience Corp. | LEXX | TURKEL CATHERINE C. Director | 5,000 | $0 | 19,900 (Direct) | View |
2022-10-12 Option Award | 2022-10-13 5:16 pm | 2022-10-12 2027-10-12 | Lexaria Bioscience Corp. | LEXX | TURKEL CATHERINE C. Director | 1,600 | $0 | 8,400 (Direct) | View |
2022-09-02 Option Award | 2022-09-06 12:53 pm | 2022-09-02 2027-09-02 | Lexaria Bioscience Corp. | LEXX | TURKEL CATHERINE C. Director | 3,400 | $0 | 3,400 (Direct) | View |
2020-03-19 Option Award | 2020-03-20 4:31 pm | N/A 2030-03-19 | Novus Therapeutics Inc. | NVUS | TURKEL CATHERINE C. President | 100,000 | $0 | 100,000 (Direct) | View |
2019-09-26 Option Award | 2019-09-30 9:30 pm | N/A 2029-09-26 | Novus Therapeutics Inc. | NVUS | TURKEL CATHERINE C. President | 75,000 | $0 | 75,000 (Direct) | View |